XML 34 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Feb. 16, 2018
Apr. 01, 2001
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 27, 2018
Jun. 30, 2018
May 19, 2017
Ownership percentage of subsidiary   100.00%              
Cash held in financial institutions     $ 12,990,240   $ 12,990,240     $ 15,350,865  
Property plant and equipment estimated useful lives, Description         Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets which range from four to ten years        
Value added tax, percentage         25.00%        
Value added tax paid to Danish and EU vendors         25.00%        
Research and development expense     788,968 $ 219,969 $ 1,282,523 $ 373,621      
Goodwill     $ 11,640,000   $ 11,640,000     $ 11,640,000  
Share exchange agreement, acquisition percentage   2.20%              
Share exchange outstanding share of common stock   129,596              
Share exchange agreement, shares issued to parent company   86,490     86,490 123,464      
Common Stock outstanding     38,789,310   38,789,310     36,163,924  
Potential dilutive shares         5,583,520        
Income Taxes Expense (Benefit)     (1,934) $ (6,572)      
Amortized the patents on a straight line basis over the estimated useful life         20 years        
Contingent Shares     5,180,429   5,180,429        
Employee And Consulting                  
Non-cash compensation     $ 1,780,059 $ 0 $ 1,866,225 $ 112,837      
Enochian Biopharma Inc. and Weird Science LLC [Member] | Agreement and Plan of Merger (the "Acquisition Agreement") [Member]                  
Shares issued on business combination 18,081,962                
Common shares contingently issuable               5,180,429  
Enochian Biopharma Inc. [Member] | Acquisition Agreement [Member]                  
Contingent Shares             1,307,693    
Enochian Biopharma Inc. [Member]                  
Ownership percentage of subsidiary                 100.00%